ALBIREO PHARMA, INC. Quarterly Debt-to-equity in % from Q2 2012 to Q3 2022

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Albireo Pharma, Inc. quarterly Debt-to-equity history and growth rate from Q2 2012 to Q3 2022.
  • Albireo Pharma, Inc. Debt-to-equity for the quarter ending September 30, 2022 was 107 %, a 56.7% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2022 107 +38.8 +56.7% Sep 30, 2022
Q2 2022 75.8 +12.9 +20.6% Jun 30, 2022
Q1 2022 74.4 +10.8 +17% Mar 31, 2022
Q4 2021 72.6 +10.9 +17.7% Dec 31, 2021
Q3 2021 68.4 +2.41 +3.65% Sep 30, 2021
Q2 2021 62.9 -13.9 -18.1% Jun 30, 2021
Q1 2021 63.6 -0.91 -1.41% Mar 31, 2021
Q4 2020 61.7 -1.45 -2.3% Dec 31, 2020
Q3 2020 66 +8.96 +15.7% Sep 30, 2020
Q2 2020 76.8 +26.4 +52.4% Jun 30, 2020
Q1 2020 64.5 +19 +41.7% Mar 31, 2020
Q4 2019 63.1 +23.1 +57.6% Dec 31, 2019
Q3 2019 57 +23.2 +68.6% Sep 30, 2019
Q2 2019 50.4 +22.6 +81.5% Jun 30, 2019
Q1 2019 45.5 +24.9 +121% Mar 31, 2019
Q4 2018 40.1 +26.6 +197% Dec 31, 2018
Q3 2018 33.8 +16.3 +93.2% Sep 30, 2018
Q2 2018 27.8 +9.15 +49.1% Jun 30, 2018
Q1 2018 20.6 -1.97 -8.74% Mar 31, 2018
Q4 2017 13.5 -4.27 -24.1% Dec 31, 2017
Q3 2017 17.5 -14.1 -44.6% Sep 30, 2017
Q2 2017 18.6 -7.7 -29.2% Jun 30, 2017
Q1 2017 22.6 +0.53 +2.41% Mar 31, 2017
Q4 2016 17.8 -7 -28.3% Dec 31, 2016
Q3 2016 31.6 +22.1 +232% Sep 30, 2016
Q2 2016 26.3 +13.8 +111% Jun 30, 2016
Q1 2016 22 +2.14 +10.8% Mar 31, 2016
Q4 2015 24.8 +2.17 +9.61% Dec 31, 2015
Q3 2015 9.51 -10.1 -51.4% Sep 30, 2015
Q2 2015 12.5 -10.8 -46.4% Jun 30, 2015
Q1 2015 19.9 -7.92 -28.5% Mar 31, 2015
Q4 2014 22.6 -6.83 -23.2% Dec 31, 2014
Q3 2014 19.6 -12.1 -38.2% Sep 30, 2014
Q2 2014 23.3 -10.1 -30.2% Jun 30, 2014
Q1 2014 27.8 -2.34 -7.76% Mar 31, 2014
Q4 2013 29.4 +3.76 +14.7% Dec 31, 2013
Q3 2013 31.7 +10.1 +46.7% Sep 30, 2013
Q2 2013 33.4 +16.9 +102% Jun 30, 2013
Q1 2013 30.1 Mar 31, 2013
Q4 2012 25.7 Dec 31, 2012
Q3 2012 21.6 Sep 30, 2012
Q2 2012 16.5 Jun 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.